Literature DB >> 10806218

ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10.

S P Zhong1, W Y Ma, Z Dong.   

Abstract

Histone H3 is the core protein of the nucleosome. Phosphorylation of H3 involves immediate early gene expression, chromatin remodeling, and chromosome condensation during mitosis. Very recently, Rsk2 or MSK1 kinase-mediated phosphorylation of H3 at serine 10 was reported. In the present study, we show that both ERKs and p38 kinase may mediate ultraviolet B-induced phosphorylation of H3 at serine 10. PD 98059, a MEK1 inhibitor, and SB 202190, a p38 kinase inhibitor, efficiently inhibited ultraviolet B-induced phosphorylation of H3. Phosphorylation of H3 was also inhibited in cells expressing dominant negative mutant (DNM) ERK2 and DNM p38 kinase. In contrast, no inhibition of H3 phosphorylation in Jnk1 or Jnk2 knockout cells (Jnk1(-/-) or Jnk2(-/-)) and cells expressing DNM JNK1 was observed. More importantly, incubation of active ERK2 or p38 kinase with H3 protein resulted in phosphorylation of H3 at serine 10 in vitro. These results suggest that ERK and p38 kinase are at least two important mediators of phosphorylation of H3 at serine 10.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806218     DOI: 10.1074/jbc.M909934199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Coordinated regulation of Nrf2 and histone H3 serine 10 phosphorylation in arsenite-activated transcription of the human heme oxygenase-1 gene.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Biochim Biophys Acta       Date:  2015-08-18

2.  The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation.

Authors:  Qun Zhao; Bassant M Barakat; Song Qin; Alo Ray; Mohamed A El-Mahdy; Gulzar Wani; El-Shaimaa Arafa; Safita N Mir; Qi-En Wang; Altaf A Wani
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

3.  Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.

Authors:  Yira Bermudez; Steven P Stratton; Clara Curiel-Lewandrowski; James Warneke; Chengcheng Hu; George T Bowden; Sally E Dickinson; Zigang Dong; Ann M Bode; Kathylynn Saboda; Christine A Brooks; Emanuel F Petricoin; Craig A Hurst; David S Alberts; Janine G Einspahr
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-01

Review 4.  Histone phosphorylation: a chromatin modification involved in diverse nuclear events.

Authors:  Dorine Rossetto; Nikita Avvakumov; Jacques Côté
Journal:  Epigenetics       Date:  2012-09-04       Impact factor: 4.528

5.  Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Authors:  Junxia Lei; Songlin Chen; Shuping Zhong
Journal:  Liver Res       Date:  2017-09-09

6.  Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control.

Authors:  Xiaoming Yang; Patricia A Wood; William J M Hrushesky
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

7.  Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.

Authors:  Hyukjin Cha; Surabhi Dangi; Carolyn E Machamer; Paul Shapiro
Journal:  Cell Signal       Date:  2005-05-31       Impact factor: 4.315

Review 8.  Chromatin-modifying enzymes as therapeutic targets--Part 2.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

9.  Role of phosphorylated histone H3 serine 10 in DEN-induced deregulation of Pol III genes and cell proliferation and transformation.

Authors:  Qian Zhong; Ganggang Shi; Qingsong Zhang; Yanmei Zhang; Daniel Levy; Shuping Zhong
Journal:  Carcinogenesis       Date:  2013-06-17       Impact factor: 4.944

10.  Talking to chromatin: post-translational modulation of polycomb group function.

Authors:  Hanneke E C Niessen; Jeroen A Demmers; Jan Willem Voncken
Journal:  Epigenetics Chromatin       Date:  2009-09-01       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.